Browse
Submit Data
Databases
API
Help

Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

62 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ATACseq of IMR32 cells treated with ISX or solvent control

ABSTRACT: IMR32 cells were treated with DMSO/ISX and open chromatin regions were assessed via ATACseq

INSTRUMENT(S): NextSeq 500

ORGANISM(S): Homo sapiens

SUBMITTER:

PROVIDER: E-MTAB-11633 | biostudies-arrayexpress |

SECONDARY ACCESSION(S): ERP137010

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

Transcriptional changes in IMR32 cells upon ISX treatment

Project description:IMR32 neuroblastoma cells were treated with ISX, a novel GLI1 inducing HDAC-inhibitor

2021-04-28 | E-MTAB-10249 | biostudies-arrayexpress

ChIPseq of IMR32 cells treated with ISX or solvent control

Project description:IMR32 cells were treated with DMSO/ISX and Histone code and MycN binding was assessed via ChIPseq.

2023-01-17 | E-MTAB-12344 | biostudies-arrayexpress

HNF4A is required to specify glucocorticoid action in the liver - ATACseq

Project description:The glucocorticoid receptor (GR) is a nuclear hormone receptor critical to the regulation of energy metabolism and the inflammatory response. The actions of GR are highly dependent on cell type and environmental context. Here, we demonstrate the necessity for liver lineage-determining factor hepatocyte nuclear factor 4A (HNF4A) in defining liver-specificity of GR action. In normal mouse liver, the HNF4 motif lies adjacent to the glucocorticoid response element (GRE) at GR binding sites found within regions of open chromatin. In the absence of HNF4A, the liver GR cistrome is remodelled, with both loss and gain of GR recruitment evident. Loss of chromatin accessibility at HNF4A-marked sites leads to loss of GR binding at weak GRE motifs. GR binding is gained at sites characterised by strong GRE motifs, which typically show GR recruitment in non-liver tissues. The functional importance of these HNF4A-regulated GR sites is further demonstrated by evidence of an altered transcriptional response to glucocorticoid treatment in the Hnf4a-null liver.

2022-01-20 | E-MTAB-10266 | biostudies-arrayexpress

Transcriptional changes in MCF7 cells upon ISX treatment

Project description:MCF7 cells were treated with ISX, a novel GLI1 inducing HDAC-inhibitor

2021-04-28 | E-MTAB-10248 | biostudies-arrayexpress

Tumor-suppressive disruption of cancer subtype-associated super enhancer1 circuits by small molecule treatment

Project description:Cell lines GIMEN and SHSY5Y were treated with ISX.

2023-01-19 | E-MTAB-11915 | biostudies-arrayexpress

PML1: IMR32 vs empty vector IMR32

Project description:Transcriptional profiling of neuroblastoma cell line expressing the PML1 isoform. Two-condition experiment: PML1 IMR32 vs empty vector IMR32. Two biological replicates, dye-swapped.

2016-08-09 | E-GEOD-78086 | biostudies-arrayexpress

ATACseq of IMR32 cells treated with ISX or solvent control

Project description:ATACseq of IMR32 cells treated with ISX or solvent control

| PRJEB52309 | ENA

Identification of a Facial Enhancer

Project description:We generated a genome-wide map of candidate enhancers from the maxillary arch (primordium for the upper jaw) of mouse embryos Examination of histone modification H3K27ac (distinguishes active enhancers from inactive enhancer elements) in the maxillary arch tissue

2014-09-02 | E-GEOD-55106 | biostudies-arrayexpress

ATACseq of mouse hematopoietic stem cells after 4 hours of LPS/PBS treatment in vivo

Project description:To understand whether hematopoietic stem cells (HSCs) take part in emergency granulopoiesis, WT C57BL6 mice were treated intraperitoneally with 35 ug of lipopolysacharide (LPS) to induce emergency granulopoiesis, or PBS control. Mice were sacrificed 4 hours after the treatment and HSCs (Lin-c-Kit+Sca-1+CD48-CD150+) were sorted and subjected to bulk ATACseq.

2023-10-16 | E-MTAB-12310 | biostudies-arrayexpress

Transcriptional changes in IMR32 cells upon ISX treatment

Project description:Transcriptional changes in IMR32 cells upon ISX treatment

| PRJEB43754 | ENA